Product Information
GABAPENTIN 300 MG CAPSULE is a generic product labeled by Mullan Pharmaceutical Inc., priced at $0.0324 per EA under NDC 83301000403. Its NADAC has been published 46 times since Aug 13, 2025.
Strength
300 mg/1
Manufacturer
Mullan Pharmaceutical Inc.NDC
83301000403
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
GABAPENTINApproval Type
Generic (ANDA)
FDA Application
ANDA075477On Market Since
5/1/2023
Pharmacological Classes
Price Statistics
The NADAC for GABAPENTIN 300 MG CAPSULE has been published 46 times since Aug 13, 2025, and over the history we have for it it has declined 9.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0324 per EA |
|---|---|
| All-time high | $0.0361 (Sep 10, 2025) |
| All-time low | $0.0324 (Jun 17, 2026) |
| 52-week high | $0.0361 |
| 52-week low | $0.0324 |
| Median price | $0.0339 |
| Average price | $0.0338 |
| Largest weekly change | -3.2% (Oct 22, 2025) |
| Weeks tracked | 46 |
| Tracking since | Aug 13, 2025 |
Generic Alternatives
The matcher finds 17 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 10 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of GABAPENTIN 300 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for GABAPENTIN 300 MG CAPSULE, manufactured by Mullan Pharmaceutical Inc., is $0.0324 per EA (NDC 83301000403), effective Jun 24, 2026.
How has the price of GABAPENTIN 300 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for GABAPENTIN 300 MG CAPSULE has declined 9.5%. It has been tracked across 46 weekly CMS publications since Aug 13, 2025.
What are the highest and lowest recorded NADAC prices for GABAPENTIN 300 MG CAPSULE?
Since Aug 13, 2025, the NADAC for GABAPENTIN 300 MG CAPSULE has ranged from a low of $0.0324 (Jun 17, 2026) to a high of $0.0361 (Sep 10, 2025), with a median of $0.0339 per EA.
Are there cheaper alternatives to GABAPENTIN 300 MG CAPSULE?
17 NADAC-published products share the same active ingredient, strength, and dosage form as GABAPENTIN 300 MG CAPSULE, but none are currently priced below it.
Who manufactures GABAPENTIN 300 MG CAPSULE?
GABAPENTIN 300 MG CAPSULE (NDC 83301000403) is labeled by Mullan Pharmaceutical Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification